Data Sharing while Using a Closed-Loop System: Qualitative Study of Adolescents' and Parents' Experiences and Views

by Allen, J.M, Besser, R.E.J, Boughton, C., Elleri, D., Fuchs, J., Ghatak, A., Hart, R.I, Hovorka, R., Kimbell, B., Lawton, J., Randell, T., Rankin, D., Thankamony, A., Trevelyan, N.
Published 2021

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Hart, R.G, Hori, M., Kakkar, A.K, Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial

by Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Commerford, P.J, COMPASS Investigators, Connolly, S.J, Cook Bruns, N., Dagenais, G.R, Dans, A., Diaz, R., Dyal, L., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T., Hart, R.G, Hori, M., Kakkar, A., Keltai, M., Kim, J.-H, Lanas, F., Leong, D., Lewis, B.S, Liang, Y., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K., Moayyedi, P., Muehlhofer, E., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J., Ryden, L., Shestakovska, O., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Verhamme, P.B, Vinereanu, D., Widimsky, P., Yusoff, K., Yusuf, S., Zhu, J.
Published 2019

Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial

by Aboyans, V., Alings, M., Anand, S.S, Avezum, A., Bhatt, D.L, Bosch, J., Branch, K.R.H, Bruns, N.C, Chen, E., Commerford, P.J, Connolly, S.J, Dagenais, G.R, Dans, A.L, Diaz, R., Eikelboom, J.W, Ertl, G., Felix, C., Fox, K.A.A, Guzik, T.J, Ha, J.-W, Hart, R.G, Hori, M., Kakkar, A., Keltai, K., Keltai, M., Kim, J.-H, Lamy, A., Lanas, F., Lanius, V., Leong, D.P, Lewis, B.S, Liang, Y., Liu, L., Lonn, E.M, Lopez-Jaramillo, P., Maggioni, A.P, Metsarinne, K.P, Misselwitz, F., Moayyedi, P., O'Donnell, M., Parkhomenko, A.N, Piegas, L.S, Pogosova, N., Probstfield, J.L, Ryden, L., Sharma, M., Steg, P.G, Störk, S., Tonkin, A.M, Torp-Pedersen, C., Varigos, J.D, Verhamme, P.B, Vinereanu, D., Widimsky, P., Yuan, F., Yusoff, K., Yusuf, S., Zhu, J.
Published 2017